Cost-Effectiveness of Stapled Hemorrhoidopexy
Author Information
Author(s): Goran Ribarić, Justus Kofler, David G. Jayne
Primary Institution: European Surgical Institute, Ethicon Endo-Surgery (Europe) GmbH, Johnson&Johnson
Hypothesis
Is stapled hemorrhoidopexy (PPH) cost-effective compared to conventional excisional hemorrhoidectomy (CH)?
Conclusion
Stapled hemorrhoidopexy is a cost-effective procedure that can lead to cost savings in routine clinical practice.
Supporting Evidence
- PPH led to a cost saving of GBP 27 per procedure compared to CH.
- An incremental QALY of 0.0076 was achieved with PPH.
- The ICER for PPH was GBP 4316, indicating high cost-effectiveness.
- Only 10% of hemorrhoidectomy procedures in the UK were performed using PPH despite its benefits.
Takeaway
This study shows that a new surgery for hemorrhoids can save money and help patients recover faster than the old method.
Methodology
A cost-utility analysis using a probabilistic, cohort-based decision tree to compare PPH with CH.
Potential Biases
Potential biases in cost data and variations in surgical practice may affect the results.
Limitations
The economic model is confined to a one-year time horizon and does not consider complications other than prolapse.
Participant Demographics
Patients undergoing initial surgical treatment of third and fourth degree hemorrhoids.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website